×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Andrew Kenneth Powell

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ACRSAclaris Therapeutics, Inc.Andrew Kenneth PowellDirectorJun 01, 2024Option/RSU Exercise-4,660-33,523Jun 04, 2024, 04:30 PM
ACRSAclaris Therapeutics, Inc.Andrew Kenneth PowellDirectorJun 02, 2023Option/RSU Exercise-4,507-14,363Jun 05, 2023, 04:50 PM
ACRSAclaris Therapeutics, Inc.Andrew Kenneth PowellDirectorNov 08, 2022Gift-4,000-9,856Jan 20, 2023, 05:08 PM
LNDCLANDEC CORP CAAndrew Kenneth PowellDirectorJun 04, 2022Award/Grant$9.507,05967,06127,477Jun 07, 2022, 05:18 PM
ACRSAclaris Therapeutics, Inc.Andrew Kenneth PowellDirectorJun 03, 2022Option/RSU Exercise-3,356-13,856Jun 06, 2022, 05:30 PM
ACRSAclaris Therapeutics, Inc.Andrew Kenneth PowellDirectorMay 16, 2022Gift-709-10,500Jun 06, 2022, 05:30 PM
ACRSAclaris Therapeutics, Inc.Andrew Kenneth PowellDirectorNov 23, 2021Gift-5,500-11,209Dec 03, 2021, 04:52 PM
LNDCLANDEC CORP CAAndrew Kenneth PowellDirectorJun 01, 2021Award/Grant$11.648,30396,64720,418Jun 03, 2021, 08:02 PM
LNDCLANDEC CORP CAAndrew Kenneth PowellDirectorOct 15, 2020Award/Grant$10.362,20022,79212,115Oct 19, 2020, 04:17 PM
ACRSAclaris Therapeutics, Inc.Andrew Kenneth PowellDirectorJun 06, 2020Option/RSU Exercise-7,333-16,709Jun 08, 2020, 05:28 PM
LNDCLANDEC CORP CAAndrew Kenneth PowellDirectorMay 28, 2020Award/Grant$10.996,00065,9409,915May 29, 2020, 03:46 PM
ACRSAclaris Therapeutics, Inc.Andrew Kenneth PowellDirectorMar 02, 2020Option/RSU Exercise-8,876-9,376Mar 04, 2020, 04:27 PM
LNDCLANDEC CORP CAAndrew Kenneth PowellDirectorMay 30, 2019Option/RSU Exercise$9.912,91528,8883,915May 30, 2019, 08:37 PM
LNDCLANDEC CORP CAAndrew Kenneth PowellDirectorJan 11, 2019Buy$11.625256,1001,000Jan 14, 2019, 02:25 PM
ACRSAclaris Therapeutics, Inc.Andrew Kenneth PowellDirectorMay 16, 2018Buy$19.125009,560500May 17, 2018, 07:34 PM